TVGN

Tevogen Inc. Common Stock

5.59

USD

+0.03

+0.54%

Nov 06, 15:59 UTC -5

Closed

After-Market

5.58

-0.01

-0.27%

Tevogen Inc. Common Stock (TVGN) Earnings

TVGN Earnings Reports

Positive Surprise Ratio

TVGN beat 1 of 1 last estimates.

100%

Next Report

Date of Next Report

Nov 12, 2026

Estimate for Q3 26 (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Tevogen Inc. Common Stock earnings per share and revenue

On Aug 12, 2026, TVGN reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q3 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Sonida Senior Living, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.54

Actual

-$0.65

Surprise

-19.11%

Nutex Health Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$5.82

Actual

$5.71

Surprise

-1.93%

Omada Health, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.01

Actual

$0.17

Surprise

+900.00%

CryoPort, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.17

Actual

-$0.25

Surprise

-38.97%

Shoulder Innovations, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.34

Surprise

+32.57%

Biodesix, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.76

Actual

-$0.75

Surprise

+1.77%

SkinHealth Systems Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$1.30

Actual

-$0.14

Surprise

+89.28%

Natera, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.29

Actual

-$0.39

Surprise

-30.65%

Viatris Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.64

Actual

$0.71

Surprise

+9.31%

Solventum Corporation

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.38

Actual

$1.45

Surprise

+5.02%

FAQ

What were Tevogen Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Tevogen Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Tevogen Inc. Common Stock's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Tevogen Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 12, 2026.

What are the forecasts for Tevogen Inc. Common Stock's next earnings report?

Based on -- analysts, Tevogen Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.